Skip to content
REGENHEALTHSOLUTIONS (RHS)

REGENHEALTHSOLUTIONS (RHS)

The best information on disruptive healthcare

  • HOME
  • ABOUT
    • CONTACT
    • PRIVACY
      • ETHICS INFORMATION
      • CLINICAL TRIALS
      • FAKE NEWS
      • UNPROVEN THERAPIES
      • RARE DISEASES
  • DIGITAL HEALTH
    • ARTIFICIAL INTELLIGENCE
    • MACHINE LEARNING
    • DEEP LEARNING
    • BIOPRINTING
      • PROSTHETIC LIMB
      • ELECTROSPINNING
    • WEARABLES
    • AUGMENTED REALITY
    • ROBOTIC SURGERY
  • MICROBIOME
  • PRECISION MEDICINE
    • CANCER
  • REGENERATIVE MEDICINE
    • ADVANCED THERAPY MEDICINAL PRODUCT
      • EMA
    • AUTOIMMUNE DISEASES
    • BIOLOGICS
    • BRAIN
    • CAR-T
    • CELL BIOLOGY
    • CELL THERAPY
      • EXOSOMES
      • iPS cells
    • DNA
    • GENE THERAPY RARE DISEASES
      • CYSTIC FIBROSIS
      • CRISPR
    • GENE EDITING
    • GENOME
    • IMMUNOTHERAPY
    • iPS cells
    • ORGAN ON CHIP
    • TISSUE ENGINEERING
  • WELLNESS
    • AGEING
  • Covid-19
    • CORONAVIRUS CHINA
  • HORIZON 2020
    • HORIZON 2020 PROJECTS
      • RESTORE LARGE SCALE RESEARCH INITIATIVE
        • Restore Health – Therapies that cure
    • RESEARCH
REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

SCIENTIFIC INFORMATION ON HEALTHCARE DISRUPTION

  • Home
  • Archive by category "CONTACT"

Category CONTACT

Follow me on Twitter

Tweets by @pierfornasari
Meaningful, tweetable quote. Click To Tweet

facebook

Follow me on:

Site’s post archive

Restore


Recent posts

  • Causes of death and comorbidities in hospitalized patients with COVID-19: the majority of patients had died of COVID-19 with only contributory implications of preexisting health conditions to the mechanism of death.
  • NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
  • FDA analysis:Janssen COVID vaccine is safe and effective also against Brazil and South Africa variant
  • B.1.351 South Africa SARS-CoV-2 Variant is immune escaping but no increase in infectivity is shown in a paper on Cell
  • Evidence of escape of SARS-CoV-2 variant B.1.351 (South Africa) from natural and vaccine induced sera. An analysis of AstraZeneca, Pfizer, Novavax and Janssen vaccine efficacy.

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. Read our Privacy Policy.

Check your inbox or spam folder to confirm your subscription.

search

Share

Social

Follow me on:

Proudly powered by WordPress | Theme: Heroic by Webriti

Designed by Pier Maria Fornasari